Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 18006872)

1.

The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.

Zulauf CA, Sprich SE, Safren SA, Wilens TE.

Curr Psychiatry Rep. 2014 Mar;16(3):436. doi: 10.1007/s11920-013-0436-6. Review.

2.

Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

Molina BS, Pelham WE Jr.

Annu Rev Clin Psychol. 2014;10:607-39. doi: 10.1146/annurev-clinpsy-032813-153722. Epub 2014 Jan 15. Review.

3.

Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.

van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W; IASP Research Group.

Drug Alcohol Depend. 2014 Jan 1;134:158-66. doi: 10.1016/j.drugalcdep.2013.09.026. Epub 2013 Oct 5.

4.

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S; IASP research group, van den Brink W, Schoevers RA.

Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20.

6.

Associations between attention deficit hyperactivity disorder symptom domains and DSM-IV lifetime substance dependence.

Ameringer KJ, Leventhal AM.

Am J Addict. 2013 Jan;22(1):23-32. doi: 10.1111/j.1521-0391.2013.00325.x.

7.

Attention deficit/hyperactivity disorder symptoms and depression symptoms as mediators in the intergenerational transmission of smoking.

Zoloto A, Nagoshi CT, Presson C, Chassin L.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):147-55. doi: 10.1016/j.drugalcdep.2012.05.003. Epub 2012 Jun 8.

8.

Addiction and cognition.

Gould TJ.

Addict Sci Clin Pract. 2010 Dec;5(2):4-14. Review.

9.

Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD.

Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2011 Jun;50(6):543-53. doi: 10.1016/j.jaac.2011.01.021. Epub 2011 Apr 22.

10.

Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.

Yang PB, Atkins KD, Dafny N.

Eur J Pharmacol. 2011 Jul 1;661(1-3):72-85. doi: 10.1016/j.ejphar.2011.04.035. Epub 2011 Apr 28.

11.

The intersection of attention-deficit/hyperactivity disorder and substance abuse.

Wilens TE, Morrison NR.

Curr Opin Psychiatry. 2011 Jul;24(4):280-5. doi: 10.1097/YCO.0b013e328345c956. Review.

12.

Do executive function deficits predict later substance use disorders among adolescents and young adults?

Wilens TE, Martelon M, Fried R, Petty C, Bateman C, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):141-9. doi: 10.1016/j.jaac.2010.11.010. Epub 2011 Jan 6.

13.

European guidelines on managing adverse effects of medication for ADHD.

Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3.

14.

Neurodevelopmental disorders: cluster 2 of the proposed meta-structure for DSM-V and ICD-11.

Andrews G, Pine DS, Hobbs MJ, Anderson TM, Sunderland M.

Psychol Med. 2009 Dec;39(12):2013-23. doi: 10.1017/S0033291709990274. Epub 2009 Oct 1. Review.

15.

Attention deficit hyperactivity disorder and blood lead levels in Chinese children.

Brondum J.

Environ Health Perspect. 2009 Jul;117(7):A286. doi: 10.1289/ehp.0900850. No abstract available.

16.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

17.

Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.

Biederman J, Petty CR, Monuteaux MC, Mick E, Clarke A, Ten Haagen K, Faraone SV.

J Child Psychol Psychiatry. 2009 Mar;50(3):352-8. doi: 10.1111/j.1469-7610.2008.02040.x.

18.

Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study.

Wilens TE, Martelon M, Kruesi MJ, Parcell T, Westerberg D, Schillinger M, Gignac M, Biederman J.

J Clin Psychiatry. 2009 Feb;70(2):259-65. Epub 2009 Feb 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk